Coronavirus vaccine program initiated by Vaxart
by Press Release from Outbreak News Today on (#4YQXB)
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that it has initiated a program to develop a coronavirus vaccine candidate based on its proprietary oral vaccine platform, VAAST. "Vaxart's proprietary technology has been clinically proven in humans, and the ability to make an oral ["]
The post Coronavirus vaccine program initiated by Vaxart appeared first on Outbreak News Today.